Deniz Medical AB

Active
559408-8352Limited company (AB)Registered 2022GÖTEBORG

Key figures

300 051 kr+525,1%
Revenue 2025
+4,5%
Average annual growth 2023–2025
0100 k200 k300 k400 k202320242025

Key figures

2025

Summary: Deniz Medical AB

What kind of company is it?

Deniz Medical AB (org. no. 559408-8352) is a limited company (AB). The company was registered in 2022 and has existed for 3 years. Registered seat: Göteborg. Industry according to Statistics Sweden: various other human health activities n.e.c. (SNI 86999).

How is the company doing financially?

Net sales in financial year 2025 were 300 051 kr, up 525 % on the previous year (47 998 kr). From 2023 to 2025, net sales grew by an average of 4,5 % per year. Net profit for 2025 was 232 220 kr (77,4 % of net sales). The company was profitable in 3 of the 4 reported financial years.

What should you look out for?

Equity was negative at the end of financial year 2025 (−96 338 kr). Equity is below half of the share capital (25 000 kr); under the Swedish Companies Act the board may then need to prepare a balance sheet for liquidation purposes (kontrollbalansräkning).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Summary of annual reports2022–2025
2021/22202320242025
Sales revenue—274 84847 998300 051
Profit for the reporting year0205 92026 702232 220
Retained earnings of previous periods————
Total assets—368 56060 20815 262
Total liabilities—137 64072 646111 600
Total equity—230 920−12 438−96 338
Employees————
Proposed dividend—000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.